AU5755898A - Formulation in the form of a matrix material-excipient compound, matrix material-active substance compound and/or matrix material-excipient-active substance compound, and processes for the preparation thereof and the use thereof for the preparation of tablets and/or other larger matrix units - Google Patents

Formulation in the form of a matrix material-excipient compound, matrix material-active substance compound and/or matrix material-excipient-active substance compound, and processes for the preparation thereof and the use thereof for the preparation of tablets and/or other larger matrix units

Info

Publication number
AU5755898A
AU5755898A AU57558/98A AU5755898A AU5755898A AU 5755898 A AU5755898 A AU 5755898A AU 57558/98 A AU57558/98 A AU 57558/98A AU 5755898 A AU5755898 A AU 5755898A AU 5755898 A AU5755898 A AU 5755898A
Authority
AU
Australia
Prior art keywords
matrix material
preparation
active substance
compound
excipient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU57558/98A
Other versions
AU732112B2 (en
Inventor
Rainer H Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DDS Drug Delivery Services Gesellschaft zur Foerderung der Forschung in Pharmazeutischer Technologie und Biopharmazie mbH
Original Assignee
DDS Drug Delivery Services Gesellschaft zur Foerderung der Forschung in Pharmazeutischer Technologie und Biopharmazie mbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1996151734 external-priority patent/DE19651734C2/en
Priority claimed from DE1997149897 external-priority patent/DE19749897C1/en
Application filed by DDS Drug Delivery Services Gesellschaft zur Foerderung der Forschung in Pharmazeutischer Technologie und Biopharmazie mbH filed Critical DDS Drug Delivery Services Gesellschaft zur Foerderung der Forschung in Pharmazeutischer Technologie und Biopharmazie mbH
Publication of AU5755898A publication Critical patent/AU5755898A/en
Application granted granted Critical
Publication of AU732112B2 publication Critical patent/AU732112B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

The invention relates to a preparation in the form of a compound containing a matrix material, with an auxiliary substance phase with at least one auxiliary substance and/or an active substance phase with at least one active substance, and a matrix material phase with at least one polymer and/or lipid. The invention is characterized in that the matrix material phase of the preparation is incoherent, and the auxiliary and/or active substance phase of the preparation is coherent. In addition, a method for the production of this preparation is described. This preparation is suited for the production of larger matrix units with controlled release characteristics in accordance with known methods, and in particular for the production of tablets by means of direct compressing.
AU57558/98A 1996-12-12 1997-12-10 Formulation in the form of a matrix material-excipient compound, matrix material-active substance compound and/or matrix material-excipient-active substance compound, and processes for the preparation thereof and the use thereof for the preparation of tablets and/or other larger matrix units Ceased AU732112B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19651734 1996-12-12
DE1996151734 DE19651734C2 (en) 1996-12-12 1996-12-12 Preparation in the form of a polymer-auxiliary compound and / or a polymer-active compound and process for its production and its use for the production of tablets and / or other larger matrix units
DE19749897 1997-11-12
DE1997149897 DE19749897C1 (en) 1997-11-12 1997-11-12 Composite especially for tablet production
PCT/EP1997/006893 WO1998025590A2 (en) 1996-12-12 1997-12-10 Preparation in form of a matrix material-auxiliary agent compound containing optionally an active substance

Publications (2)

Publication Number Publication Date
AU5755898A true AU5755898A (en) 1998-07-03
AU732112B2 AU732112B2 (en) 2001-04-12

Family

ID=26032146

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57558/98A Ceased AU732112B2 (en) 1996-12-12 1997-12-10 Formulation in the form of a matrix material-excipient compound, matrix material-active substance compound and/or matrix material-excipient-active substance compound, and processes for the preparation thereof and the use thereof for the preparation of tablets and/or other larger matrix units

Country Status (9)

Country Link
EP (1) EP0948321B1 (en)
JP (1) JP2001505899A (en)
AT (1) ATE252378T1 (en)
AU (1) AU732112B2 (en)
BR (1) BR9713702A (en)
CA (1) CA2274832A1 (en)
DE (1) DE59710904D1 (en)
NZ (1) NZ336225A (en)
WO (1) WO1998025590A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
IT1304152B1 (en) * 1998-12-10 2001-03-08 Mediolanum Farmaceutici Srl COMPOSITIONS INCLUDING A PEPTIDE AND POLYLACTIC-GLYCOLIC ACID FOR THE PREPARATION OF SUBCUTANEOUS IMPLANTS HAVING A PROLONGED
GB9921933D0 (en) * 1999-09-17 1999-11-17 Univ Gent Solid shaped articles comprising biologically active substances and a method for their production
ES2326040T3 (en) 2001-10-19 2009-09-29 Isotechnika Inc. SYNTHESIS OF CYCLOSPORINE ANALOGS.
DE10315917A1 (en) 2003-04-08 2004-11-18 Schwarz Pharma Ag Highly pure bases of 3,3-diphenylpropylamine monoesters
DE10318897B4 (en) * 2003-04-22 2007-04-26 Levin, Felix, Dr. Stabilized universal test formulation and test kit for protein determination in biological fluids
DE102008047910A1 (en) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tabletting excipient based on lactose and cellulose
DE102009011805A1 (en) * 2009-03-05 2010-09-09 Almapharm Gmbh & Co. Kg Tableting excipient, useful e.g. to produce food supplement and/or feeding stuff, comprises a condensation core and a fat, which is coated to condensation core, where condensation core and fat are connected together by spray drying
EP3002005A1 (en) 2014-09-30 2016-04-06 Molkerei Meggle Wasserburg GmbH & Co. Kg Direct compression excipient based on lactose, cellulose and starch

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3505433A1 (en) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen DIRECT TABLETING AIDS
DE3506276C1 (en) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direct tableting
DE4122591C1 (en) * 1991-07-08 1993-02-18 Roland 8012 Ottobrunn De Bodmeier Producing microcapsules of water insoluble polymer and active agent - includes dissolving or dispersing active agent in aq. polymer contg. gellable assistants
US5350584A (en) * 1992-06-26 1994-09-27 Merck & Co., Inc. Spheronization process using charged resins
AT403988B (en) * 1994-05-18 1998-07-27 Lannacher Heilmittel SOLID ORAL RETARDED PREPARATION
JPH0977669A (en) * 1995-09-19 1997-03-25 Takeda Chem Ind Ltd Vitamin b group granular product composition and its production

Also Published As

Publication number Publication date
CA2274832A1 (en) 1998-06-18
WO1998025590A3 (en) 1998-10-01
WO1998025590A2 (en) 1998-06-18
EP0948321B1 (en) 2003-10-22
ATE252378T1 (en) 2003-11-15
NZ336225A (en) 2001-03-30
JP2001505899A (en) 2001-05-08
AU732112B2 (en) 2001-04-12
DE59710904D1 (en) 2003-11-27
EP0948321A2 (en) 1999-10-13
BR9713702A (en) 2000-10-31

Similar Documents

Publication Publication Date Title
AU578577B2 (en) Devices for the controlled release of active substances, as well as process for the preparation thereof
CA2034934A1 (en) Transdermal Therapeutic System Comprising Tulobuterol as Active Substance
NZ231832A (en) Pharmaceutical or cosmetic composition for topical application containing microspheres of diameter 3-10mum
MX9500159A (en) Percutaneous pharmaceutical preparation.
NO964939D0 (en) Process for the preparation of active ingredient preparations in the form of a solid solution of the active ingredient in a polymer matrix, as well as active ingredient preparations prepared by this process.
IL137882A0 (en) Nanoparticles comprising at least one polymer and at least one compound able to complex one or more active ingredients
AU7702291A (en) Dietary fiber, its process and physiologically active composition containing the same as an active ingredient
CA2309252A1 (en) Process for preparing a detergent tablet
CA2010218A1 (en) Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substances
WO1996011949A3 (en) Analogs of keratinocyte growth factor
AU528310B2 (en) Composition of paracetamol and metoclopramide
FR2754820B1 (en) MAGNESIUM (-) HYDROXYCITRATE, PREPARATION METHOD, APPLICATIONS, AND PARTICULARLY PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
AU5356986A (en) Teilchen aus euner hydrophoben oder schwerloslichen substanz und verfahren zur ihrer hydrophilisierung
AU5755898A (en) Formulation in the form of a matrix material-excipient compound, matrix material-active substance compound and/or matrix material-excipient-active substance compound, and processes for the preparation thereof and the use thereof for the preparation of tablets and/or other larger matrix units
CA2047744A1 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
IE831226L (en) Method for preparing 26,26,26,27,27,27-hexafluoro-1ó,25-¹dihydrocholestrol
GR3025823T3 (en) High concentrated, solid mepiquat chloride and chlormequat chloride products
DE69431162D1 (en) Fenbendazolformulierungen
AU2895397A (en) Novel substance library and supramolecular complexes prepared therewith
WO1999047543A3 (en) Sustained-release composition including amorphous polymer
MX9705806A (en) Medicament form for the delivery of collagenase to wounds and process for the preparation thereof.
AU3946197A (en) Cosmetic, dermatological and pharmaceutical use of a terminalia catappa extract
AU4884596A (en) Process for the preparation of a solid pharmaceutical dosage form
AU4113797A (en) Method of preparing (s) - or (r) -3,3,3-trifluoro-2-hydroxy-2- methylpropionic acid
WO1997000671A3 (en) Composition for preparing finely dispersed systems and process for preparing the same

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)